Literature DB >> 6471217

Urodynamic evaluation of incontinence in patients undergoing modified Campbell radical retropubic prostatectomy: a prospective study.

D C Rudy, J R Woodside, E D Crawford.   

Abstract

A prospective urodynamic study was performed on 17 consecutive patients undergoing a modified Campbell radical retropubic prostatectomy for prostatic carcinoma. There was 1 postoperative death, leaving 16 evaluable patients. Patients were evaluated preoperatively and at 6 weeks, 3 months and 6 months postoperatively. The only urodynamic parameter 6 months postoperatively that differed significantly from the preoperative value was the functional urethral length, 1.6 and 4.3 cm., respectively. The incidence of clinical and/or urodynamic urinary incontinence preoperatively was 19 per cent and 6 months after the procedure it was 87 per cent. The incontinence rate did not correlate with the pathological stage or histological grade of the tumor. There was a strong trend toward improvement of continence with time but all patients who were incontinent 6 months postoperatively and followed for more than 1 year remained incontinent. While this incontinence rate is the highest reported, we believe that it reflects detailed patient interviews and objective fluoroscopic evidence of urethral urinary loss. These results and those of others suggest that modification of the technique of radical prostatectomy to produce a functional urethral length of at least 2.8 cm. may be desirable.

Entities:  

Mesh:

Year:  1984        PMID: 6471217     DOI: 10.1016/s0022-5347(17)49836-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

Review 1.  Assessment and therapy for voiding dysfunction after prostatectomy.

Authors:  Rodney A Appell
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

2.  Antegrade techniques of collagen injection for post-prostatectomy stress urinary incontinence: the Washington University experience.

Authors:  M A Wainstein; C G Klutke
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  [Epidemiology and etiology of male urinary incontinence].

Authors:  C Hampel; J W Thüroff; R Gillitzer
Journal:  Urologe A       Date:  2010-04       Impact factor: 0.639

Review 4.  The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.

Authors:  P T Scardino
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 5.  [Etiology and pathophysiology of male stress incontinence].

Authors:  C van der Horst; C M Naumann; A Al-Najaar; C Seif; S H Stübinger; K P Jünemann; P M Braun
Journal:  Urologe A       Date:  2007-03       Impact factor: 0.639

6.  Management of recurrent post-prostatectomy incontinence after previous failed retrourethral male slings.

Authors:  Amr Al-Najar; Sascha Kaufmann; Soenke Boy; Carsten Maik Naumann; Peter-Klaus Jünemann; Christof Van Der Horst
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

Review 7.  The treatment of stress incontinence in men: part 2 of a series of articles on incontinence.

Authors:  Christof Börgermann; Albert Kaufmann; Herbert Sperling; Manfred Stöhrer; Herbert Rübben
Journal:  Dtsch Arztebl Int       Date:  2010-07-09       Impact factor: 5.594

8.  [Functional retrourethral sling. A change of paradigm in the treatment of stress incontinence after radical prostatectomy].

Authors:  C Gozzi; R M Bauer; A J Becker; I Schorsch; F May; P Rehder; C G Stief; P J Bastian
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

Review 9.  Preoperative exercise interventions to optimize continence outcomes following radical prostatectomy.

Authors:  Sean F Mungovan; Sigrid V Carlsson; Gregory C Gass; Petra L Graham; Jaspreet S Sandhu; Oguz Akin; Peter T Scardino; James A Eastham; Manish I Patel
Journal:  Nat Rev Urol       Date:  2021-04-08       Impact factor: 14.432

10.  Male incontinence: Pathophysiology and management.

Authors:  Ajay K Singla
Journal:  Indian J Urol       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.